| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,869 |
14,394 |
$1.56M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
11,992 |
10,319 |
$1.52M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28,461 |
24,451 |
$1.27M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14,999 |
12,220 |
$1.12M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,455 |
8,766 |
$689K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,924 |
6,304 |
$614K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14,840 |
12,067 |
$403K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,150 |
8,488 |
$265K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,524 |
9,174 |
$199K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,825 |
7,319 |
$116K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,623 |
1,510 |
$58K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
933 |
731 |
$28K |
| 99051 |
|
4,154 |
3,628 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
4,228 |
3,545 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
273 |
186 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
522 |
428 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
494 |
423 |
$7K |
| 90686 |
|
517 |
375 |
$5K |
| 99072 |
|
12,121 |
10,616 |
$5K |
| 99000 |
|
5,140 |
4,557 |
$3K |
| 90674 |
|
65 |
61 |
$2K |
| 86769 |
|
215 |
166 |
$2K |
| 81003 |
|
841 |
780 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
49 |
31 |
$1K |
| 87807 |
|
81 |
75 |
$1K |
| 81025 |
|
118 |
113 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17 |
17 |
$779.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
40 |
$404.40 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
109 |
103 |
$388.12 |
| 90688 |
|
14 |
12 |
$215.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
143 |
134 |
$151.37 |
| 82962 |
|
46 |
45 |
$134.63 |
| S9083 |
Global fee urgent care centers |
1,742 |
1,673 |
$124.11 |
| 36416 |
|
249 |
205 |
$75.53 |
| 81002 |
|
32 |
27 |
$68.22 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
17 |
12 |
$1.97 |